In vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases

BACKGROUND: NXL104 is a novel-structure β-lactamase inhibitor with potent activity against both class A and class C enzymes. Among the class A carbapenemases, KPC-type enzymes are now spreading rapidly and KPC-related carbapenemase resistance is an emerging phenomenon of great clinical importance. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Stachyra, Thérèse, Levasseur, Premavathy, Péchereau, Marie-Claude, Girard, Anne-Marie, Claudon, Monique, Miossec, Christine, Black, Michael T.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707266/
https://www.ncbi.nlm.nih.gov/pubmed/19493866
http://dx.doi.org/10.1093/jac/dkp197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707266/
https://www.ncbi.nlm.nih.gov/pubmed/19493866
http://dx.doi.org/10.1093/jac/dkp197

Ejemplares similares